Variable | Multivariate analyses | |
---|---|---|
HR (95% CI) | p value | |
The VS45 Model | ||
 Age (per year increase) | 0.979 (0.967–0.991) | 0.001* |
 Female (vs male) | 1.690 (1.231–2.319) | 0.001* |
 Chemotherapy (vs no) | 1.194 (0.758–1.881) | 0.444 |
 Thyrotoxicosis (vs no) | 0.638 (0.459–0.887) | 0.008* |
 Thyroid VS45 (per cm3 increase) | 0.876 (0.833–0.920) | 0.000* |
The VS50 Model | ||
 Age (per year increase) | 0.979 (0.967–0.992) | 0.001* |
 Female (vs male) | 1.658 (1.207–2.278) | 0.002* |
 Chemotherapy (vs no) | 1.284 (0.818–2.015) | 0.277 |
 Thyrotoxicosis (vs no) | 0.656 (0.472–0.913) | 0.012* |
 Thyroid VS50 (per cm3 increase) | 0.883 (0.844–0.924) | 0.000* |
The VS55 Model | ||
 Age (per year increase) | 0.981 (0.968–0.993) | 0.002* |
 Female (vs male) | 1.637 (1.190–2.250) | 0.002* |
 Chemotherapy (vs no) | 1.435 (0.918–2.242) | 0.113 |
 Thyrotoxicosis (vs no) | 0.665 (0.478–0.926) | 0.016* |
 Thyroid VS55 (per cm3 increase) | 0.905 (0.871–0.940) | 0.000* |
The VS60 Model | ||
 Age (per year increase) | 0.982 (0.970–0.994) | 0.004* |
 Female (vs male) | 1.652 (1.203–2.268) | 0.002* |
 Chemotherapy (vs no) | 1.562 (1.002–2.435) | 0.049 |
 Thyrotoxicosis (vs no) | 0.677 (0.485–0.944) | 0.021* |
 Thyroid VS60 (per cm3 increase) | 0.921 (0.891–0.951) | 0.000* |